Hip’s Don’t Lie: Hip Replacement Surgery ‘same day procedure’

Same day hip replacement procedure is now an outpatient procedure and is trending due to its popular surgical technique used.  3-inch incision is made, which is minimally invasive without muscle cuttings leading to faster recovery. This surgery is performed on specialized surgical table that resulting in less post-operative pain. Hence, surgeons are recommending patients with […]

Read More

Regenerative Medicine and Stem Cells: Promises to Cure the Uncurable

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the “process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function”. Stem cell therapy is the emerging field in the regenerative medicine and holds the promise of engineering damaged tissues and […]

Read More

Veritas Capital to Acquire a GE Healthcare IT Business

Veritas Capital plans to acquire a health-care technology unit from General Electric. The company announced on 2nd April, 2018, that it entered into a definitive agreement with GE to acquire the Enterprise Financial Management (Revenue-Cycle, Centricity Business), Ambulatory Care Management (Centricity Practice Solution) and Workforce Management (formerly API Healthcare) assets comprising GE Healthcare’s Value-Based Care […]

Read More

GSK and Novartis – Consumer Healthcare Collaboration

The British pharma giant GlaxoSmithKline has had a consumer health joint venture with Switzerland’s Novartis for the last few years. However, GSK has just struck a $13 billion deal with its partner to take control of the whole thing in March, 2018, after quitting the race to buy Pfizer’s consumer healthcare business. Under the terms […]

Read More

Pharmaceutical Drugs Going off Patent in 2018

Patent expiry is one of the major factor affecting the company revenue. Often when the generic competitor of a blockbuster drugs enters the market, the sales of the blockbuster drugs has decreased significantly. For instance, the patent expiry of Pfizer’s Lipitor has resulted in about 90% decrease in the annual sales revenue of the drug. […]

Read More

Liquid biopsy – Emergence of a New Era in Diagnostics

Liquid biopsy also known as Fluid biopsy, is a minimally invasive technology that identifies molecular biomarkers using blood, urine or other liquid samples to detect various disease conditions such as cancer, prenatal testing and transplantation diagnostics without the need of invasive procedures. Circulating tumor cells (CTCs), Circulating free DNA (cfDNA), Circulating small-RNA and extracellular micro-vesicles […]

Read More

2017 Life Science Deals

Looking back at 2017 The year of 2017 has been dynamic, and a lot of activities have supported the life science market growth. This year has not been great for the business deals in US, however, the European counterparts have been more active when compared to US. This was due to the effect of tax […]

Read More

Reimbursement Scenario in the US

Background Healthcare situations across the globe are finding different ways to limit their increasing expense and is forcing manufacturers to diversify and put pressure on the prices of medical devices globally with cost-effective benefits. The opportunities for health insurers especially for people aged above 65 (also known as baby boomers) are gaining advantages from the […]

Read More

Blockchain in Healthcare

Blockchain is a distributed register that is used to keep track of the transactions happening in numerous machines. Every organization emphases on delivering high quality care to their clients. This requirement becomes even more important in the Healthcare industry. However, the major challenge is that the devices/service providers and customers control the decisions, which lead […]

Read More